Chronic microvascular changes (small vessel ischaemia)

Chronic microvascular changes, often called cerebral small vessel disease, happen when the tiny blood vessels deep inside the brain become stiff, thick, and narrow over time. This narrowing reduces blood flow, starving brain cells of oxygen and causing progressive tissue damage.

On an MRI, this damage shows up as bright white spots called white matter hyperintensities. These spots mark areas where the brain's protective insulation (myelin) is wearing down or where tiny, silent strokes (lacunar infarcts) and minuscule leaks (microhaemorrhages) have occurred.

While mild changes are a common part of aging and usually harmless, moderate to severe damage significantly increases your risk of stroke, memory loss, vascular dementia, balance problems, and depression.

Chronic microvascular changes develop silently over years and frequently cause no obvious symptoms in their early stages. As the burden of white matter damage increases, subtle and then more significant symptoms emerge:

• Mild cognitive slowing, reduced processing speed, and difficulty with multitasking

• Memory difficulties, particularly for recent events

• Reduced concentration and mental stamina

• Mood changes including depression, apathy, and emotional lability

• Subtle gait changes, a slightly shuffling or unsteady walk, from disruption of subcortical motor pathways

• Urinary urgency from disruption of bladder control pathways

• In more advanced disease: significant cognitive impairment meeting criteria for vascular dementia, prominent gait disturbance, and recurrent falls

The pattern of cognitive impairment in cerebral small vessel disease tends to affect executive function, processing speed, and attention more than memory in its early stages, distinguishing it from Alzheimer's disease where memory loss typically predominates.

Chronic microvascular changes result from sustained damage to the brain's small blood vessels from vascular risk factors accumulated over years or decades. Contributing causes include:

• Hypertension: the leading cause; high blood pressure stiffens and thickens vessel walls, narrowing them and cutting off blood flow.

• Diabetes: high blood sugar directly damages vessel linings, accelerating small vessel decay.

• Smoking and dyslipidaemia: smoking destroys vessel walls, while abnormal cholesterol hardens arteries and reduces blood flow control.

• Age: small vessel damage naturally accumulates over time, becoming much more common and severe after age 60.

• Elevated homocysteine and inflammation: high homocysteine and chronic inflammation both irritate and weaken blood vessel linings.

• Sleep apnoea: repeated drops in oxygen and sudden spikes in blood pressure at night accelerate vessel damage.

• Genetics: rare inherited conditions (like CADASIL) can cause severe, early-onset small vessel disease in younger adults.

Chronic microvascular changes are detected through brain MRI, with blood tests identifying the modifiable vascular risk factors driving their development and progression.

Brain MRI Elfcare’s full-body MRI can detect small vessel disease long before symptoms appear. It flags white matter hyperintensities, grades their severity, and checks for other signs like silent lacunar infarcts or microhaemorrhages. Mapping the exact pattern of these findings helps identify the underlying cause and guides steps to protect brain health going forward.

Blood tests cannot detect microvascular changes directly but identify the modifiable vascular risk factors most strongly driving their development. Relevant markers in Elfcare's panel include:

• HbA1c and glucose: high blood sugar damages vessel linings, accelerating brain tissue loss.

• Total cholesterol, LDL, HDL, ApoB, Lp(a): abnormal lipids stiffen arteries, restricting healthy blood flow.

• Homocysteine, B12 and folate: vitamin deficiencies raise homocysteine, a toxic compound linked to rapid vessel decay.

• CRP: measures chronic inflammation, which weakens the blood-brain barrier.

• Creatinine and eGFR: chronic kidney disease is closely associated with cerebral small vessel disease through shared vascular mechanisms.

• TSH: Thyroid imbalances disrupt overall cardiovascular and brain health.

Why early detection matters

Chronic microvascular changes are largely irreversible once established, but how fast they progress is highly modifiable with aggressive vascular risk factor management. Catching white matter changes before they've caused significant cognitive impairment or a clinical stroke gives the widest window to intervene. Blood pressure control is the single most effective intervention, reducing both the rate of new lesions forming and the risk of an acute lacunar stroke. Catching these changes early, while the brain still has substantial cognitive reserve, opens the door to intervention that preserves function and reduces the risk of vascular dementia and stroke for years to come.

How Elfcare can help

Elfcare's full body MRI includes comprehensive brain imaging as standard, directly identifying white matter hyperintensities, lacunar infarcts, and cerebral microhaemorrhages that constitute chronic microvascular changes. Grading the severity of these findings provides an objective measure of cumulative vascular brain injury and establishes a baseline against which future progression can be assessed.

Our blood panel covers the complete vascular risk profile including HbA1c, lipids, homocysteine, CRP, kidney function, and thyroid markers, identifying the modifiable drivers of small vessel disease and providing a direct basis for risk reduction intervention.

If our MRI or blood tests identify significant microvascular changes or high-risk vascular profiles, we take care of further diagnostics or refer you to the appropriate specialist.